Nearly 30% of UK adult population is affected by obesity, creating a high demand for innovative weight management solutions. In the quest for effective weight loss solutions, injections like Mounjaro and Wegovy have emerged as prominent players. These treatments have gained attention for their role in managing obesity, a growing health concern globally.
Is Mounjaro equivalent to Wegovy? Although they are both weight loss drugs powered by similar mechanisms influencing appetite regulation but they are not exactly the same.
In this comprehensive guide, we’ll delve into the specifics of these medications, comparing their efficacy, safety profiles, mechanisms of action, and user experiences to determine which might be the best choice for your weight loss journey.
– Wegovy is made by Novo Nordisk and contains the active ingredient Semaglutide, whereas
– Mounjaro is produced by Eli Lilly and contains Tirzepatide.
– Both weight loss injections can be obtained via prescription only.
– Mounjaro has Tirzepatide and Wegovy has Semaglutide, and they work differently. Mounjaro activates both GLP-1 and GIP receptors, while Wegovy only activates the GLP-1 receptor.
– Clinical trials suggest that Mounjaro leads to more weight loss compared to Wegovy. On average, patients using Mounjaro lose about 25% of their weight after one year, while those on Wegovy lose around 16%.
Mounjaro (Tirzepatide) and Wegovy (Semaglutide) have been the talk of the town since they were launched in the UK. Wegovy was launched in September 2023. However, Mounjaro has recently been approved in the UK by MHRA for chronic weight management.
Wegovy, or Semaglutide, functions primarily through the GLP-1 receptor agonism pathway. By mimicking GLP-1, it slows gastric emptying, induces satiety, and leads to a substantial decrease in appetite and caloric intake.
Mounjaro, known generically as Tirzepatide, is not only a GLP-1 receptor agonist but also incorporates the effects of GIP (Glucose-dependent Insulinotropic Polypeptide). This dual-action approach is designed to enhance weight loss by improving insulin secretion, reducing hunger, and potentially improving metabolic efficiency.
Although these weight loss injections contain different active ingredients, they have some similar characteristics and the potential to achieve similar goals in your weight loss journey.
The other major difference between Wegovy and Mounjaro is the dosing schedules.
Wegovy is available in five different strengths, and you take one dose each week. Every four weeks, your Wegovy dose is increased until you reach the maintenance dose. This final dose, which is usually either 1.7mg or 2.4mg, will be determined by your GP.
The clinical licensing for Wegovy clearly states that doses must be increased each month until the maximum 2.4 mg maintenance dose is reached.
All Wegovy doses include:
– 0.25mg
– 0.5mg
– 1mg
– 1.7mg
– 2.4mg
Mounjaro is slightly different because it has 6 different doses:
2.5 mg,
5 mg
7.5mg
10mg
12.5mg
15 mg.
Mounjaro has 3 different maintenance dosages – 5 mg, 10 mg and 15 mg. However, only two Mounjaro dosages i.e. 2.5 mg and 5 mg are currently available at The Care Pharmacy.
This means there’s currently more flexibility with Mounjaro’s dosing schedules than Wegovy.
If you feel you are getting good weight-loss results at a lower maintenance dose of Mounjaro (e.g. 5 mg or 10 mg), you don’t need to increase the dose further.
Mounjaro also has ‘escalation’ doses, which you’ll be required to take for four weeks if you decide to move up from one maintenance dose to another.
For example, if your current maintenance dose is 5 mg and you want to move up to a 10mg maintenance dose, you’ll need to spend 4 weeks on the 7.5 mg escalation dose.
Wegovy’s side effects may include:
Less common but serious risks involve pancreatitis, gallbladder problems, low blood sugar in diabetics on other medications, kidney dysfunction, and potential thyroid C-cell tumour risk.
Common side effects associated with Mounjaro include:
Talk to your healthcare provider about any side effect that bothers you or doesn’t go away.
Mounjaro works better than Wegovy for weight loss. In a 72-week study, 96% of people on the highest dose of Manjaro lost at least 5% of their initial weight. In a similar study, 84% of those taking the highest dose of Wegovy achieved the same weight loss.
While both drugs can lead to significant weight loss, it’s also important to remember that the extent of effectiveness can vary based on individual factors such as body mass index (BMI), existing health conditions and adherence to the treatment plan.
You can switch from Wegovy to Mounjaro, but they’re not interchangeable, which means they can’t be used simultaneously.
Additionally, if you replaced Wegovy with Mounjaro, you might need to start at the lowest dose of Mounjaro and gradually titrate up to the higher doses.
This will depend on your current situation and whether our clinical team determines which dose is safe for you to transition to.
For example, if you’re on 2.4 mg of Wegovy (the highest dose) and switched to Mounjaro, you might have to start on the lowest dose of Mounjaro, 2.5 mg.
However, our clinical team might determine that 5 mg of Mounjaro is safe for you to transition to if your current situation allows it.
Yes, Mounjaro (Tirzepatide) is available in the UK. It has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for both weight management and as a treatment for type 2 diabetes. For weight management, it can be used by adults with a Body Mass Index (BMI) of 30 kg/m² or more, or those with a BMI of 27-30 kg/m² who have weight-related health conditions like prediabetes, high blood pressure, high cholesterol, or heart disease.
You can buy Mounjaro online after an online consultation with our healthcare professionals at The Care Pharmacy.
Medically reviewed by
Superintendent Pharmacist
If you are researching whether weight loss injections are safe, you are likely looking beyond headlines and marketing claims. You want clarity on real risks, long-term safety, side effects, monitoring, and whether these treatments are appropriate for you personally. Weight loss injections such as GLP-1 based medications are now widely prescribed in the UK, both through […]
If you are experiencing mounjaro constipation, you are not alone. Constipation is a well recognised side effect of Mounjaro and other GLP-1 based weight loss treatments. For many people, it is mild and temporary. For others, it can be uncomfortable enough to affect daily life and confidence in continuing treatment. From the perspective of The […]
If you are researching the best weight loss capsules, you are not alone. Many people begin their weight loss journey by looking for tablets or capsules before considering injectable treatments. At The Care Pharmacy, we support patients across the UK with honest, clinically led advice so they can understand which options are most effective, safe, […]
Many people exploring prescription weight loss treatments ask the same question. Is Saxenda right for me, or are there other options that may work better? With increasing awareness of injectable weight loss treatments, it is important to understand how Saxenda compares with other injections and with traditional weight loss methods. This guide explores how Saxenda […]
Interest in weight loss injections UK services has grown rapidly as more people look for clinically supported ways to manage their weight. At The Care Pharmacy, we provide regulated online access to private weight loss injections, supported by clinical assessment, ongoing review, and clear expectations around results and safety. If you are considering private treatment […]
Mounjaro can cause diarrhoea because tirzepatide slows digestion and changes gut motility, leading to more frequent bowel movements as your body adjusts. Diarrhoea is a common and usually short-term side effect, especially in the first few weeks or after a dose increase. In this guide, you’ll understand the exact reasons diarrhoea can happen on Mounjaro […]
